Related Experiment Video
Updated: May 16, 2026
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
pEGFP-N1-mediated BmK CT expression suppresses the migration of glioma
Yuejun Fu1, Yanmei Jiao, Na An
1Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, 030006, People's Republic of China, yjfu@sxu.edu.cn.
Abstract:
Gliomas can diffuse into the normal brain and this invasion of glioma cells involves modification of receptor-mediated adhesive properties of tumor cells, degradation and remodeling of extracellular matrix by tumor-secreted metalloproteinase (MMPs) such as MMP-2, consequently creating an intercellular space for invasion of glioma cells. BmK CT, one of the key toxins in scorpion Buthus martensii Karsch venom, is a novel blocker of the chloride ion channel and MMP-2. In this report, a recombinant plasmid pEGFP-N1-BmK CT was constructed and characterized by in vitro studies. The results showed that pEGFP-N1 mediated BmK CT expression displayed a high activity in suppressing cell migration via MMP-2. The potential therapeutic effect of pEGFP-N1 mediated BmK CT against rat glioma C6 cells was assessed and its potential mechanism was elucidated. It represented an approach for developing a novel therapeutic agent-recombinant plasmid pEGFP-N1-BmK CT as an efficient and powerful adjuvant.
Insights
This study explored using a scorpion toxin (BmK CT) to inhibit glioma cell invasion by blocking MMP-2. The recombinant plasmid pEGFP-N1-BmK CT effectively suppressed glioma cell migration, showing therapeutic potential.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biochemistry
Background:
- Glioma invasion into normal brain tissue is facilitated by tumor cell adhesion and extracellular matrix degradation.
- Matrix metalloproteinase-2 (MMP-2) plays a crucial role in glioma cell invasion by remodeling the extracellular matrix.
- Scorpion venom toxin BmK CT is identified as a novel blocker of chloride ion channels and MMP-2.
Purpose of the Study:
- To construct and characterize a recombinant plasmid expressing BmK CT (pEGFP-N1-BmK CT).
- To evaluate the efficacy of pEGFP-N1-BmK CT in suppressing glioma cell migration.
- To assess the therapeutic potential and mechanism of pEGFP-N1-BmK CT against rat glioma C6 cells.
Main Methods:
- Construction and in vitro characterization of the recombinant plasmid pEGFP-N1-BmK CT.
- Assessment of BmK CT's activity in suppressing cell migration, specifically targeting MMP-2.
- Evaluation of the therapeutic effect of pEGFP-N1-BmK CT on rat glioma C6 cells.
Main Results:
- The expressed BmK CT via pEGFP-N1 demonstrated significant activity in suppressing cell migration.
- Suppression of cell migration was primarily mediated through the inhibition of MMP-2.
- The recombinant plasmid showed potential therapeutic effects against rat glioma C6 cells.
Conclusions:
- Recombinant plasmid pEGFP-N1-BmK CT effectively suppresses glioma cell migration by inhibiting MMP-2.
- This approach offers a novel therapeutic strategy for glioma treatment.
- pEGFP-N1-BmK CT shows promise as an efficient and powerful adjuvant therapy for gliomas.
